Senior insider sale
Chief Executive Officer at PASITHEA THERAPEUTICS CORP. — senior position signals high conviction
$797.76
960.00 shares
What this filing means
MARQUES TIAGO plans to sell 960.00 shares of PASITHEA THERAPEUTICS CORP. valued at approximately $797.76. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/14/2025ACC: 0001213900-25-043622
DirectorOfficer· Chief Executive Officer
Since Sep 2021
960.00
Shares to sell
$797.76
Approx. market value
960.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Open market purchase
Cash
11/25/2022
100.00Open market purchase
Cash
11/23/2022
360.00Open market purchase
Cash
10/21/2022
250.00Open market purchase
Cash
6/23/2022
250.00Total acquired960.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/25/2022 | Open market purchase Cash | 100.00 | — |
11/23/2022 | Open market purchase Cash | 360.00 | — |
10/21/2022 | Open market purchase Cash | 250.00 | — |
6/23/2022 | Open market purchase Cash | 250.00 | — |
| Total | 960.00 | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
960.00
Market value
$797.76
5/12/2025
Total
Units
960.00
Value
$797.76
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/12/2025 | 960.00 | $797.76 | Nasdaq | Planned |
| Total | 960.00 | $797.76 | ||